Takeda to Expand Presence in Asia with Operations in South Korea
Takeda Pharmaceutical Company Limited announced it will establish a new commercial subsidiary in South Korea. Takeda aims to increase its global market coverage to approximately 90 percent by the end of fiscal 2012, one of the key strategic initiatives of the 2010-2012 Mid-Range Plan.
The South Korean pharmaceutical market is the 15th largest in the world with an almost 10 percent growth rate projected for the next several years, according to IMS data. With more than 48 million people, South Korea is one of the largest pharmaceutical markets in which Takeda does not have a direct presence and a key market for Takeda’s Asian strategy. Takeda’s expansion into Korea will increase the value of Takeda’s portfolio, address a sizeable territory coverage gap and strengthen Takeda’s reputation in Asia.
The new subsidiary will conduct sales and marketing of key products for the Korean market. Upon establishment, Takeda will build the infrastructure necessary to support further growth of the organization.
Other news from the department business & finance
